Stay updated on HMPL-689 Safety & PK in Lymphomas Clinical Trial
Sign up to get notified when there's something new on the HMPL-689 Safety & PK in Lymphomas Clinical Trial page.

Latest updates to the HMPL-689 Safety & PK in Lymphomas Clinical Trial page
- Check2 days agoChange DetectedA service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours beginning at 9 PM EDT.SummaryDifference0.7%
- Check9 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.5, with the removal of estimated dates for results posting and last updates.SummaryDifference0.8%
- Check16 days agoChange DetectedThe clinical development of HMPL-689 has been halted by HUTCHMED, and several key dates related to results reporting have been updated. Additionally, detailed information regarding adverse events and pharmacokinetic parameters has been added, enhancing the understanding of the drug's safety and efficacy.SummaryDifference85%
- Check23 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe web page has been updated from version v2.16.1 to v2.16.2.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
Stay in the know with updates to HMPL-689 Safety & PK in Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-689 Safety & PK in Lymphomas Clinical Trial page.